203 related articles for article (PubMed ID: 17944752)
1. Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma.
Harper LJ; Piper K; Common J; Fortune F; Mackenzie IC
J Oral Pathol Med; 2007 Nov; 36(10):594-603. PubMed ID: 17944752
[TBL] [Abstract][Full Text] [Related]
2. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
[TBL] [Abstract][Full Text] [Related]
3. The effects of CD44 down-regulation on stem cell properties of head and neck cancer cell lines.
Kidwai F; Costea DE; Hutchison I; Mackenzie I
J Oral Pathol Med; 2013 Oct; 42(9):682-90. PubMed ID: 23627635
[TBL] [Abstract][Full Text] [Related]
4. Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties.
Gou S; Liu T; Wang C; Yin T; Li K; Yang M; Zhou J
Pancreas; 2007 May; 34(4):429-35. PubMed ID: 17446842
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
Srivastava VK; Nalbantoglu J
Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
[TBL] [Abstract][Full Text] [Related]
6. CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.
Chen YS; Wu MJ; Huang CY; Lin SC; Chuang TH; Yu CC; Lo JF
PLoS One; 2011; 6(11):e28053. PubMed ID: 22140506
[TBL] [Abstract][Full Text] [Related]
7. CD44+ cancer cell-induced metastasis: A feasible neck metastasis model.
Wu TF; Chen L; Bu LL; Gao J; Zhang WF; Jia J
Eur J Pharm Sci; 2017 Apr; 101():243-250. PubMed ID: 28215944
[TBL] [Abstract][Full Text] [Related]
8. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
[TBL] [Abstract][Full Text] [Related]
9. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.
Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM
Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333
[TBL] [Abstract][Full Text] [Related]
10. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells hypothesis and stem cells in head and neck cancers.
Mannelli G; Gallo O
Cancer Treat Rev; 2012 Aug; 38(5):515-39. PubMed ID: 22197808
[TBL] [Abstract][Full Text] [Related]
12. Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells.
Morrison BJ; Steel JC; Morris JC
PLoS One; 2012; 7(11):e49752. PubMed ID: 23152931
[TBL] [Abstract][Full Text] [Related]
13. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck.
Okamoto A; Chikamatsu K; Sakakura K; Hatsushika K; Takahashi G; Masuyama K
Oral Oncol; 2009 Jul; 45(7):633-9. PubMed ID: 19027347
[TBL] [Abstract][Full Text] [Related]
14. Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics.
Gilormini M; Wozny AS; Battiston-Montagne P; Ardail D; Alphonse G; Rodriguez-Lafrasse C
J Vis Exp; 2016 May; (111):. PubMed ID: 27213496
[TBL] [Abstract][Full Text] [Related]
15. Biological characteristics of a cell subpopulation in tongue squamous cell carcinoma.
Sun Y; Han J; Lu Y; Yang X; Fan M
Oral Dis; 2012 Mar; 18(2):169-77. PubMed ID: 22023137
[TBL] [Abstract][Full Text] [Related]
16. CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer.
Liu TJ; Sun BC; Zhao XL; Zhao XM; Sun T; Gu Q; Yao Z; Dong XY; Zhao N; Liu N
Oncogene; 2013 Jan; 32(5):544-53. PubMed ID: 22469978
[TBL] [Abstract][Full Text] [Related]
17. [Multiparametric flow cytometry analyzes the expressions of immunophenotype CD133, CD34, CD44 in lung cancer naive cells].
Liu D; Li WM; Mo XM; Liu LX; Wang Y; Che GW; Wu Z; Gou JL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):827-31. PubMed ID: 19024325
[TBL] [Abstract][Full Text] [Related]
18. Isolation and identification of cancer stem-like cells from murine melanoma cell lines.
Dou J; Pan M; Wen P; Li Y; Tang Q; Chu L; Zhao F; Jiang C; Hu W; Hu K; Gu N
Cell Mol Immunol; 2007 Dec; 4(6):467-72. PubMed ID: 18163959
[TBL] [Abstract][Full Text] [Related]
19. Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system.
Fan X; Liu S; Su F; Pan Q; Lin T
Urol Oncol; 2012; 30(3):314-8. PubMed ID: 20843707
[TBL] [Abstract][Full Text] [Related]
20. Targeted inhibition of CD133+ cells in oral cancer cell lines.
Damek-Poprawa M; Volgina A; Korostoff J; Sollecito TP; Brose MS; O'Malley BW; Akintoye SO; DiRienzo JM
J Dent Res; 2011 May; 90(5):638-45. PubMed ID: 21220361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]